| Prevalence of rearrangements in the 22q11. 2 region and population-based risk of neuropsychiatric and developmental disorders in a Danish population: a case-cohort study L Olsen, T Sparsø, SM Weinsheimer, MBQ Dos Santos, W Mazin, ... The Lancet Psychiatry 5 (7), 573-580, 2018 | 127 | 2018 |
| Risk of psychiatric disorders among individuals with the 22q11. 2 deletion or duplication: a Danish nationwide, register-based study LK Hoeffding, BB Trabjerg, L Olsen, W Mazin, T Sparsø, A Vangkilde, ... JAMA psychiatry 74 (3), 282-290, 2017 | 105 | 2017 |
| Pattern formation in the bistable Gray-Scott model W Mazin, KE Rasmussen, E Mosekilde, P Borckmans, G Dewel Mathematics and Computers in Simulation 40 (3-4), 371-396, 1996 | 101 | 1996 |
| A 71-gene signature of TRAIL sensitivity in cancer cells JJ Chen, S Knudsen, W Mazin, J Dahlgaard, B Zhang Molecular cancer therapeutics 11 (1), 34-44, 2012 | 56 | 2012 |
| Development and validation of a gene expression score that predicts response to fulvestrant in breast cancer patients S Knudsen, T Jensen, A Hansen, W Mazin, J Lindemann, I Kuter, N Laing, ... PLoS One 9 (2), e87415, 2014 | 34 | 2014 |
| Wave-splitting in the bistable Gray-Scott model KE Rasmussen, W Mazin, E Mosekilde, G Dewel, P Borckmans International Journal of Bifurcation and Chaos 6 (06), 1077-1092, 1996 | 28 | 1996 |
| Differential DNA methylation at birth associated with mental disorder in individuals with 22q11. 2 deletion syndrome A Starnawska, CS Hansen, T Sparsø, W Mazin, L Olsen, M Bertalan, ... Translational psychiatry 7 (8), e1221-e1221, 2017 | 27 | 2017 |
| Expression of microRNAs in the NCI-60 cancer cell-lines SK Patnaik, J Dahlgaard, W Mazin, E Kannisto, T Jensen, S Knudsen, ... PloS one 7 (11), e49918, 2012 | 27 | 2012 |
| Development and blind clinical validation of a microRNA based predictor of response to treatment with R-CHO (E) P in DLBCL S Knudsen, C Hother, K Grønbæk, T Jensen, A Hansen, W Mazin, ... PloS one 10 (2), e0115538, 2015 | 23 | 2015 |
| Independent validation of a model using cell line chemosensitivity to predict response to therapy W Wang, KA Baggerly, S Knudsen, J Askaa, W Mazin, KR Coombes Journal of the National Cancer Institute 105 (17), 1284-1291, 2013 | 20 | 2013 |
| Analytical variables influencing the performance of a miRNA based laboratory assay for prediction of relapse in stage I non-small cell lung cancer (NSCLC) J Dahlgaard, W Mazin, T Jensen, M Pøhl, W Bshara, A Hansen, E Kanisto, ... BMC research notes 4, 1-12, 2011 | 11 | 2011 |
| Methods and devices for prognosis of cancer relapse S Knudsen, W Mazin US Patent App. 14/119,008, 2014 | 8 | 2014 |
| Perspectives for an integrated biomarker approach to drug discovery and development I Antonijevic, R Artymyshyn, C Forray, S Rabacchi, K Smith, C Swanson, ... Biomarkers for Psychiatric Disorders, 355-403, 2008 | 4 | 2008 |
| IPSYCHCNV: A robust method for copy number variation detection on dried blood spots M Bertalan, S Weinsheimer, T Sparso, W Mazin, T Werge European Neuropsychopharmacology 27, S163-S164, 2017 | 3 | 2017 |
| Existing data sources for clinical epidemiology: Aarhus university clinical trial candidate database, Denmark H Nørrelund, W Mazin, L Pedersen Clinical Epidemiology, 129-135, 2014 | 2 | 2014 |
| A classifier driven approach to find biomarkers for affective disorders from transcription profiles in blood W Mazin, JA Tamm, IA Antonijevic, A Abdourahman, M Das, ... Advances in Precision Medicine 1 (1), 2016 | 1 | 2016 |
| Exploring the biological basis of affective disorders W Mazin | 1 | 2008 |
| DIFFERENTIAL DNA METHYLATION AT BIRTH ASSOCIATED WITH MENTAL DISORDER IN INDIVIDUALS WITH 22Q11. 2 DELETION SYNDROME A Starnawska, C Hansen, T Sparsø, W Mazin, L Olsen, M Bertalan, A Buil, ... European Neuropsychopharmacology 29, S918, 2019 | | 2019 |
| THE DANISH CYTOGENETIC CENTRAL REGISTER: POPULATION-BASED SURVIVAL ANALYSIS OF MENTAL DISORDERS AMONG CARRIERS OF CHROMOSOMAL ABNORMALITIES L Hoeffding, BB Trabjerg, A Vangkilde, L Olsen, CB Pedersen, T Werge, ... EUROPEAN NEUROPSYCHOPHARMACOLOGY 27, S303-S304, 2017 | | 2017 |
| Methods and devices for prognosis of cancer relapse S Knudsen, W MAZIN | | 2016 |
